Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. EAT

Go back to Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
Corcept Therapeutics, Inc. (NASDAQ: CORT) Delayed: 111.62 -1.18 (1.05%)
Previous Close $112.80    52 Week High $10.00 
Open $110.59    52 Week Low $3.22 
Day High $112.13    P/E N/A 
Day Low $109.26    EPS $-0.46 
Volume 604,557